Abstract
Recent advancements in nanotechnology have opened avenues to address the selectivity challenges in targeted drug delivery systems, minimizing adverse effects. While carbon nanotubes (CNTs) have gained traction as drug carriers, their B, N-containing counterpart, pristine boron carbonite (p-BC4N), remains underexplored. This study investigates the possibility of pristine boron carbonite (p-BC4N) nanotubes as a drug carrier for the anticancer medication cisplatin (CPT). Using first-principles Density Functional Theory (DFT) simulations, we examined the interaction between CPT and p-BC4N nanotubes, revealing favourable adsorption energies (−0.523 eV) due to orbital interactions and charge transfer between the C 2p orbitals of BC4N and the 1 s orbitals in H of CPT. Ab initio molecular dynamics (AIMD) simulations confirmed the stability of the system at room temperature. Furthermore, pH and temperature-dependent desorption measurements demonstrated the effectiveness of p-BC4N nanotubes as a promising candidate for CPT drug delivery, highlighting their potential in targeted cancer therapy. This work opens up new avenues for the development of nanotechnology-based drug delivery systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
